Healthcare in your pocket

You, me and 23andMe: discovering new medicines through genetics

Overcoming obstacles to end malaria

One of our lead physicians, Justin Green, tells us about the challenges of developing a new treatment for malaria.

The little pill that could: one medicine taking on two neglected diseases

This pill is part of the fight against not one – but two – neglected tropical diseases(NTDs) that burden some of the very poorest communities.

Severe asthma: when nature’s natural defences work against us

Around 36 million people around the world are living with severe asthma. But, hope could be on the horizon thanks to a better understanding of how certain blood cells malfunction.

Complete the cycle – how we’re recycling inhalers

When we analysed our carbon footprint in 2010, two things became clear: we needed to take action to reduce it.

Why are we fighting malaria in the lab and on the ground?

How do consumer insights fuel our innovation?

How genomics is driving a new era of drug discovery

We’re in a new era of drug discovery because of a fundamental change in our understanding of human biology.

How are we redefining research in HIV?

Shari Gordon works in the HIV Cure Center in North Carolina, a public-private company with one goal: discovering a cure for HIV/AIDS.

Following the journey of a respiratory medicine

Elaine Jones explains how her passion for helping respiratory patients live every breath motivates her in developing new medicines.

Lupus: the search for a cure continues

Doctors and their patients face an ongoing battle to manage this chronic and sometimes debilitating and life-threatening condition. See how we’re trying to help.

COPD for John just means doing everything at a slower pace

Making the Ellipta® inhaler a reality

Welcome to the golden age of vaccine innovation

Join our leading scientists as they go behind the science of one of the most-effective interventions in modern medicine

Overcoming the challenges of COPD to fulfil a lifelong dream

Joan an 85 year old COPD patient recently achieved her lifelong dream to climb the Great Wall of China. Her daughter Helen tells us Joan’s story.

Making sense of what consumers want

As a Principal Sensory Scientist in our Consumer Sensory Lab, Hyung describes how we develop products that spark the sensory reaction consumers want.

The science of shopping

Every day millions of consumers use our products. Different countries have different needs and consumers’ shopping habits vary hugely.

Breaking through the pain barrier: our latest research

I control my asthma, it doesn’t control me

Thank you for calling GSK. Meet Paul, the voice at the end of the line.

When you call us, who’s the voice at the end of the line? Paul tells his story from scientist to sympathetic ear.

You'll outgrow some childhood habits, but vaccination is for life

Infectious diseases remain just as serious throughout adulthood and vaccines remain the most effective protection we have against them.

How curious minds saved a medicine from being left in the lab

See how Steve and his team refined their scientific focus in order to deliver our first biologic respiratory medicine.

Does lupus really know no boundaries?

There are no boundaries when it comes to the impact of lupus; it can affect any part of the body in any way at any time, often with unpredictable and life-changing results.

From TV to tackling lupus: why Alex moved from media to medicine

Giving a bit back – Christine’s experience of clinical research

Healthcare in your pocket

We are dedicated to supporting patients beyond the medicines we provide and believe that digital technology, has an important role to play in this.

The race against malaria: handing the baton to the next generation

Malaria is a preventable and treatable disease yet it still claims hundreds of thousands of lives each year, mostly in children under five.

Win for Meningitis – harnessing the power of inspirational images to create a win for disease prevention

Through our Win for Meningitis campaign, we’re helping to raise awareness of this damaging disease.

Setting the record straight: Why we publish data both positive and negative

Sharing our trial results, regardless of whether they reflect positively or negatively on our medicines is the right thing to do.

Making the switch: how we’re improving access to proven medicines

Supporting community health across the UK

30 years and counting: the fight against HIV

How to find a treatment for a disease with no idea what that disease actually is.

HIV research focus on finding a cure

With 34 million people around the world living with HIV/AIDS, preventing and treating HIV infection remains an enormous global challenge.

What are Bioelectronics

We’re all familiar with the life-saving impact of pacemakers and defibrillators on the heart.

Live every breath

GSK have been innovating to fight respiratory disease for over 45 years.

Vaccines: the most successful health intervention… ever

Joining forces to fight malaria

STEM inspiring real world scientists

GSK STEM Education brings real world science to life in the classroom.

The digitalisation lab: bringing the digital age to manufacturing

We are developing world-class manufacturing innovation to help us bring medicines and consumer healthcare products to people.

From academia to the pharmaceutical industry – one year on

Professor Ronald Dahl recently joined GSK as a Global Medical Expert in the GSK Global Respiratory Franchise.

COPD: Our relentless pursuit for better breathing

Every person with COPD is different, with different needs, different challenges and different goals. See how we're innovating to determine the right treatment for the right patient.

Taking action to stop pneumonia

Getting on target in autoimmune diseases

How smart is your inhaler?

As we investigate new treatments, the ‘internet of things,’ is allowing us to explore the benefits of interconnectivity and the rich patient data that these technologies can provide.

Maternal immunisation: Helping protect mums and babies

Immunisation during pregnancy can help protect the mother, and also help protect the baby before birth and through the critical first few weeks of life.

Can social media help us hear patients?

Understanding the benefits and risks of medicine from a patient’s point of view is important to the evaluation of our medicines.

Tackling tomorrow’s health challenges today

Our Chief Scientist, Rino Rappuoli, explains how science is helping create the vaccines of tomorrow

Don’t forget the pharmacists

Rabies – Educate, Vaccinate, Eliminate.

Partnership for Prevention

Anthony Tropea has been part of the team leading the roll-out of our Partnership for Prevention Programme.

Scientists or detectives? Seeking new clues in COPD

It is now widely accepted that COPD is not a uniform disease, but effects of the disease can impact people differently.

Collaboration: unlocking a new approach to clinical trials

The Salford Lung Study is a revolutionary clinical trial carried out in everyday practice that could significantly increase our understanding of the medicines doctors prescribe.

Helping to change the world

FORTUNE Magazine published its 2016 list of companies that are changing the world, and we are honored to be ranked #1.

A new response to humanitarian crises

A partnership that is all about the chemistry

Can an iPhone transform the way we monitor and improve patient health?

We are using digital technologies and channels to improve the efficiency of our research, and to improve patient care.

The app that could save lives

How our partnership with Save the Children is boosting healthcare innovation that supports vulnerable children.

Changing gears in a scientific career

GSK medic, Emma Hilton, tells us about her career in science and how she makes hard work easier.

Inhaler innovation: more than a simple piece of plastic

At first glance, an inhaler may look like a simple piece of plastic. But inside, a complicated process and an internal ‘engine’ operate seamlessly...

From microscope to telescope and beyond – exploring with NASA's CASIS

Meet Baby Mckline: a special delivery from our Save the Children partnership

Pro Mujer: supporting healthier lives in Latin America

Since 2009, we have been working with Pro Mujer, helping women like Rosa lift themselves and their families out of poverty, and giving them access to high-quality, low-cost healthcare, often for the first time.

From academia to industry: a new challenge

Professor Christopher Cooper joined GSK as a Global Medical Expert, Scientific Faculty, GSK Global Respiratory Franchise. Here he explains why he chose to move from academia to industry.

The design behind the device

Andy Dundon leads our R&D Device Engineering team in Ware, UK. His team focuses on ways to improve the design of our drug delivery devices

An 'everyday' world first in clinical trials

The way we design and carry out clinical trials is being turned on its head by the advent of the Salford Lung Study (SLS).

Turning the tide on antibiotic resistance

Guardian article: The 30-year quest for a malaria vaccine

Clinical Trials: Q&A with Murray Stewart

Dr. Murray Stewart is our Chief Medical Officer. In this role, he is the most senior physician at GSK, and has overall responsibility for patient well-being across vaccines, pharmaceutical and consumer medicines. He also oversees medical ethics and integrity.

Giving mothers and babies a healthier start

Find out how our scientists have adapted an ingredient from a GSK mouthwash into a potentially life-saving gel for newborns in developing countries

Safety first: Employee wellbeing rides on it

Rajendra is a medical representative in India. He commutes 30 kilometres everyday by motorcycle - and that doesn't even include the time spent on the road during the day.

Vaccine manufacture: it’s complicated

Vaccine manufacture can take anywhere between 6 and 26 months. That’s not to mention the time required to research and develop a new vaccine, which can take up to 30 years.

The power of partnerships: transforming vaccine coverage in Mozambique

The value of vaccination

Beyond manufacturing in Chile and Madagascar

In 2015, GSK Vaccines sent two vaccine manufacturing teams to South America and Africa to better understand the impact of their daily work.

Why I #fightmalaria: Laura's story

Laura is a scientist and a mum. Here she describes what motivates her to fight against malaria.

Playing the innovation game

Besides good timing and even better luck, it’s hard to pinpoint what it takes to be an innovator. Innovators tend to be creative, exceptionally persistent, and prepared to take calculated risks.

Living with lupus – a patient perspective

Beth, a lupus patient, provides insights into the day-to-day challenges of living with this chronic condition.

Does the relationship between the pharma industry and HCPs need to change?

Take a deep breath – your lung microbiome will appreciate it

Helping to further science and research – Howard’s perspective

The Salford Lung Study is a ground breaking clinical trial that explores how effective a treatment for COPD is in everyday life.

TB or not TB

As recently as 30 years ago, tuberculosis (TB) was believed to be under control.

Unlocking the secrets of the immune system to tackle disease

Paul-Peter Tak, Chief Immunology Officer and Senior Vice President R&D Pipeline, GSK, highlights the work we're doing to explore the immune system.

Bioelectronics at SXSW 2016

SXSW Interactive is a cutting edge technology and digital festival that brings together the brightest minds in emerging technology.

Delivering support for the most vulnerable communities

School leading the way to inspire young scientists

Harnessing the electrical language of the body to treat disease

Bioelectronic medicine is a vision far from today’s medical practice. But we believe that one day, tiny devices, smaller than grains of rice, could be used to restore health in a range of chronic diseases centred on organs and biological functions.

Telegraph article: Science hasn't answered all the questions on HIV

Dr Kimberly Smith, vice president of medical strategy at ViiV Healthcare, shares her experiences of a career spent working to find a cure for the disease.

Igniting a revolution in scientific research and development

How can partnerships between science, business and charities help tackle some of the world's most challenging healthcare issues?

Guardian article: Making a change from the inside

Allan Pamba recalls his experiences as a doctor in Kenya and why he decided to work for ‘the enemy' - a pharmaceutical company.

Guardian article: A different way of doing business to support Kenyan mothers

See how GSK supports STEM in the real world

Guardian article: Finding new ways to give mothers and newborns a healthier start

Scientist Lori Gavrin has first-hand experience of why we need to find new ways to help protect mothers and their newborn babies

Disclosing information on payments to doctors has already had positive effects in Europe

Find out how we will be publicly disclosing information on payments and transfers of value that we make to doctors and other healthcare professionals (HCPs).

Turning waste into a resource

We set a target to achieve ‘zero waste to landfill’ at all our sites by 2020. Already, over 60% of GSK sites and offices have achieved the target.

Simon Wright, Head of Child Survival at Save the Children gives a partnership perspective

Simon Wright, Head for Child Survival at Save the Children, talks about how we’re working together to make sure the health needs of the world’s poorest children are at the top of everyone’s agenda.

Comic Relief and GSK form a partnership to fight malaria

Intrapreneurship: keeping our fingers on the PULSE

Turbocharging the effect of vaccines

When extracted and purified, a compound from the soap bark tree can be mixed with other ingredients to create an ‘adjuvant’, turbocharging the body's immune defences.

Helping to protect yourself against flu

Influenza, commonly called ‘the flu’, is a contagious infection of the respiratory tract, which affects people of all ages.

Experimental medicine

Studies often employ state-of-the art technology to help scientists and doctors track the effect of a potential new medicine in patients’ bodies.

Outgrowing asthma

Why is it that some people, particularly children, grow out of their asthma? That’s a question our scientists are asking as part of our research to better understand the disease.

TEDMED 2015: An interview with curator, Christine McNab

STEM in the real world

TEDMED 2015: Art, inspired by vaccination

A blank canvas, Unformed clay. An empty petri dish.

Living every day with COPD: José’s story

Simple activities are an everyday struggle for people living with COPD. José gives his perspective on the impact that COPD has on him.

Guardian article: Why I put my signature on improving care for Kenya's mothers and newborns

Angela Muriuki finds that combating the high death rates in mothers and newborns in parts of Kenya involves knowledge of the culture of the people involved and the practical problems they face accessing healthcare.

Less is more with advanced technologies in manufacturing

Is ‘continuous manufacturing’ the best way to be greener?

Using biology to increase quality and reduce carbon footprint

Five years. 40,000 health workers. 11 million people.

Targeting the immune system through open innovation

A functioning immune system is crucial to our health - but what is its role beyond such things as keeping colds at bay and fighting infections?

To challenge. To change.

At GSK we’re taking on some of the world’s biggest healthcare challenges. We're on a mission to help people do more, feel better, live longer.

Health workers fighting it on the frontline

Almost everyone in Tanzania is at risk of malaria. The mosquito-borne disease is responsible for more than 10% of deaths among children under five in this East African country.

No 'silver bullet' to tackle this disease

The combination of increased funding, resources and education to fight malaria have contributed to a reduction in deaths from this mosquito-borne disease.

On the frontline of Ebola prevention

Ebola: our fast track response

Keeping ahead of the game

To be the best at what we do, we rely on innovative science to create products capable of transforming the lives of patients.

Fluorescent bacteria - nowhere to hide

How can a new approach known as “bacteria-instructed synthesis” help to tackle bacterial infection?

Making our vaccines more accessible

We are determined to use our resources, knowledge and expertise to help improve access to immunisation.

Vaccines - coming in from the cold

‘Thermostability’ - it may sound very technical and complicated, but really it’s all about fridges.

Motivating a global coalition

Cell and gene therapy: a new era of medicine

Fighting Ebola highlights the need for more health workers

The Ebola crisis is by far the worst outbreak of the disease the world has ever seen.

The race to richer data in clinical trials

Finding new ways to use biosensors and mobile health platforms to improve patient care.

Why our transaction with Novartis is different

What makes GSK’'s transaction with Novartis different?

Ebola vaccine R&D

Learn how we are advancing the development of our GSK/NIH Ebola vaccine candidate.

Forming public partnerships

Our humanitarian response to the Ebola outbreak

A healthier future for Africa

Our VP of east Africa and government affairs, Allan Pamba, explains his desire to improve the health of people in Africa.

The critical workers boosting children’s health

As a community health worker in Liberia – communities rely on people like Christopher for essential healthcare.

Flonase: the journey from prescription to OTC

Switching a product from a prescription medicine to over the counter (OTC) is nothing to sniff at.

Africa’s fight against malaria: how mothers are helping on the ground

In a critical year in the fight against malaria, it will be community health workers and mothers themselves who play a vital role in helping to defeat the disease in Africa

Increasing access in India

Helping women to give birth safely

Science of a different stripe

How do the stripes in toothpaste get into the tubes and how is it that they come out of it so uniformly?

Bacteria: friends or foes?

What if instead of trying to see off the bugs, we harnessed them and made them work for us, instead of against us?

Can mosquitoes prevent malaria?

Find out how we are breeding 2,000 mosquitoes every week in the search for anti-malarial medicines.

Data transparency

We have a long-standing commitment to data transparency.

Inside the Open Lab

Neuroscience: on the brain

The 'baby bubble'

The first 48 hours of life can be critical for a newborn baby. Infections like pneumonia, contracted during a baby’s first two days, can prove fatal.

Eggs in manufacturing

Chickens. Where would we be without them? Well for one thing, we wouldn’t have nearly as many influenza vaccines as we need.

Novamin - the accidental curist

One of the more compelling aspects of scientific research is the unexpected avenues down which it can lead.

'Rightsizing' our tablet packaging to reduce carbon emissions

How can you fit six tablets into the same space as four – and why would you want to?

Green chemistry

Life after polio: Fatiha's story